Therapeutic Targets Database
BIDD Pharmainformatics Databases


TTD Target ID: TTDR01369

Target Information
NamemRNA of human 5-lipoxygenase    
Type of targetResearch target    
DiseaseNot Available
UniProt IDP09917
PDB Structure2ABV; 3O8Y; 3V92; 3V98; 3V99.    
Target ValidationClick to Find Target Validation Information.    
Inhibitor (+)-3,3'-bisdemethyltanegool[1]
1- (4-methoxyphenyl)-3-[4]
1- (4-methoxyphenyl)-3-[4]
1- (4-methoxyphenyl)-3-[4]
2,4'-Diacetoxy-5,3'-di- (2-propenyl)-biphenyl[5]
2,4'-Dimethoxy-5,3'-di- (2-propenyl)-biphenyl[5]
2,4,5-Triarylimidazole analogue[6]
2- (4-methoxyphenyl)-N-[4]
2- (benzyloxy)naphthalene[7]
2-phenyl-N- (1,3,4-thiadiazol-2-yl)acetamide[4]
2-phenyl-N- (thiazol-2-yl)acetamide[4]
3,4,5-trimethoxy-N- (thiazol-2-yl)benzamide[4]
3-methoxy-N- (1,3,4-thiadiazol-2-yl)benzamide[4]
3-methoxy-N- (4-methylthiazol-2-yl)benzamide[4]
4- (dimethylamino)-N-[4]
4-methoxy-N- (thiazol-2-yl)benzamide[4]
Methyl 2- (Benzylamino)-1H-indole-3-carboxylate[3]
Methyl 2- (Diallylamino)-1H-indole-3-carboxylate[3]
N- (1,3,4-thiadiazol-2-yl)benzamide[4]
N- (3-phenoxycinnamyl)-N-hydroxyacetamide[13]
N- (4-methylthiazol-2-yl)-2-phenylacetamide[4]
N- (4-methylthiazol-2-yl)benzamide[4]
N- (5-methylthiazol-2-yl)-2-phenylacetamide[4]
N- (5-methylthiazol-2-yl)benzamide[4]
N- (thiazol-2-yl)benzamide[4]
N-hydroxy-N-[1- (4-isobutylphenyl)ethyl]urea[14]
N-hydroxycarbamate derivative[15]
N-hydroxycarbamate derivative[15]
N-hydroxycarbamate derivative[15]
N-hydroxycarbamate derivative[15]
N-hydroxycarbamate derivative[15]
N-hydroxycarbamate derivative[15]
isojaspic acid[2]
jaspic acid[2]
AntisenseISIS 1820[18]
ISIS 1821[18]
ISIS 1822[18]
ISIS 1827[18]
ISIS 1831[18]
ISIS 2177[18]
Cross References 3D Structure
Related Literature
On-Line Medical Dictionary
Ref 1J Nat Prod. 2007 May;70(5):859-62. Epub 2007 Mar 23.Lipoxygenase inhibitory constituents of the fruits of noni (Morinda citrifolia) collected in Tahiti. To Reference
Ref 2J Nat Prod. 2009 Oct;72(10):1857-63.Using enzyme assays to evaluate the structure and bioactivity of sponge-derived meroterpenes. To Reference
Ref 3J Med Chem. 2009 Jun 11;52(11):3474-83.Structural optimization and biological evaluation of 2-substituted 5-hydroxyindole-3-carboxylates as potent inhibitors of human 5-lipoxygenase. To Reference
Ref 4J Med Chem. 2007 May 31;50(11):2640-6. Epub 2007 Apr 27.Identification of natural-product-derived inhibitors of 5-lipoxygenase activity by ligand-based virtual screening. To Reference
Ref 5Bioorg Med Chem. 2009 Jul 1;17(13):4459-65. Epub 2009 May 18.Design and synthesis of ten biphenyl-neolignan derivatives and their in vitro inhibitory potency against cyclooxygenase-1/2 activity and 5-lipoxygenase-mediated LTB4-formation. To Reference
Ref 6Bioorg. Med. Chem. Lett. 5(11):1171-1176 (1995) To Reference
Ref 7Nat Chem Biol. 2009 Aug;5(8):585-92. Epub 2009 Jun 28.Bioactivity-guided mapping and navigation of chemical space. To Reference
Ref 8J Med Chem. 2005 Oct 20;48(21):6523-43.Designed multiple ligands. An emerging drug discovery paradigm. To Reference
Ref 9J Nat Prod. 2001 Oct;64(10):1297-300.Inhibition of leukocyte functions by the alkaloid isaindigotone from Isatis indigotica and some new synthetic derivatives. To Reference
Ref 10J Med Chem. 1993 Sep 17;36(19):2771-87.Substituted thiopyrano[2,3,4-c,d]indoles as potent, selective, and orally active inhibitors of 5-lipoxygenase. Synthesis and biological evaluation of L-691,816. To Reference
Ref 11J Med Chem. 1997 Aug 29;40(18):2866-75.Substituted (pyridylmethoxy)naphthalenes as potent and orally active 5-lipoxygenase inhibitors; synthesis, biological profile, and pharmacokinetics of L-739,010. To Reference
Ref 12Bioorg Med Chem Lett. 2006 May 1;16(9):2528-31. Epub 2006 Feb 7.Substituted coumarins as potent 5-lipoxygenase inhibitors. To Reference
Ref 13J Med Chem. 2008 Sep 11;51(17):5449-53. Epub 2008 Aug 19.Novel and potent inhibitors of 5-lipoxygenase product synthesis based on the structure of pirinixic acid. To Reference
Ref 14J Med Chem. 1997 Feb 28;40(5):819-24.Nonsteroidal anti-inflammatory drugs as scaffolds for the design of 5-lipoxygenase inhibitors. To Reference
Ref 15Bioorg Med Chem Lett. 2005 Feb 15;15(4):1083-5.5-Lipoxygenase inhibition by N-hydroxycarbamates in dual-function compounds. To Reference
Ref 16J Med Chem. 1998 Aug 27;41(18):3515-29.New cyclooxygenase-2/5-lipoxygenase inhibitors. 3. 7-tert-butyl-2, 3-dihydro-3,3-dimethylbenzofuran derivatives as gastrointestinal safe antiinflammatory and analgesic agents: variations at the 5 position. To Reference
Ref 17Bioorg Med Chem. 2010 Jun 1;18(11):3910-24. Epub 2010 Apr 18.Synthesis and biological activity of N-aroyl-tetrahydro-gamma-carbolines. To Reference
Ref 18US Patent 5530114 To Reference


Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.

Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links


Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543